Cargando…

Erratum to: Development and Evaluation of a New Technological Way of Engaging Patients and Enhancing Understanding of Drug Tolerability in Early Clinical Development: PROACT

Detalles Bibliográficos
Autores principales: Hughes, Andrew, Landers, Donal, Arkenau, Hendrik-Tobias, Shah, Saj, Stephens, Richard, Mahal, Amrik, Simmons, Matthew, Lemech, Charlotte, Royle, Jennifer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5020106/
https://www.ncbi.nlm.nih.gov/pubmed/27464766
http://dx.doi.org/10.1007/s12325-016-0390-x
_version_ 1782453175359373312
author Hughes, Andrew
Landers, Donal
Arkenau, Hendrik-Tobias
Shah, Saj
Stephens, Richard
Mahal, Amrik
Simmons, Matthew
Lemech, Charlotte
Royle, Jennifer
author_facet Hughes, Andrew
Landers, Donal
Arkenau, Hendrik-Tobias
Shah, Saj
Stephens, Richard
Mahal, Amrik
Simmons, Matthew
Lemech, Charlotte
Royle, Jennifer
author_sort Hughes, Andrew
collection PubMed
description
format Online
Article
Text
id pubmed-5020106
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Springer Healthcare
record_format MEDLINE/PubMed
spelling pubmed-50201062016-09-27 Erratum to: Development and Evaluation of a New Technological Way of Engaging Patients and Enhancing Understanding of Drug Tolerability in Early Clinical Development: PROACT Hughes, Andrew Landers, Donal Arkenau, Hendrik-Tobias Shah, Saj Stephens, Richard Mahal, Amrik Simmons, Matthew Lemech, Charlotte Royle, Jennifer Adv Ther Erratum Springer Healthcare 2016-07-27 2016 /pmc/articles/PMC5020106/ /pubmed/27464766 http://dx.doi.org/10.1007/s12325-016-0390-x Text en © The Author(s) 2016 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Erratum
Hughes, Andrew
Landers, Donal
Arkenau, Hendrik-Tobias
Shah, Saj
Stephens, Richard
Mahal, Amrik
Simmons, Matthew
Lemech, Charlotte
Royle, Jennifer
Erratum to: Development and Evaluation of a New Technological Way of Engaging Patients and Enhancing Understanding of Drug Tolerability in Early Clinical Development: PROACT
title Erratum to: Development and Evaluation of a New Technological Way of Engaging Patients and Enhancing Understanding of Drug Tolerability in Early Clinical Development: PROACT
title_full Erratum to: Development and Evaluation of a New Technological Way of Engaging Patients and Enhancing Understanding of Drug Tolerability in Early Clinical Development: PROACT
title_fullStr Erratum to: Development and Evaluation of a New Technological Way of Engaging Patients and Enhancing Understanding of Drug Tolerability in Early Clinical Development: PROACT
title_full_unstemmed Erratum to: Development and Evaluation of a New Technological Way of Engaging Patients and Enhancing Understanding of Drug Tolerability in Early Clinical Development: PROACT
title_short Erratum to: Development and Evaluation of a New Technological Way of Engaging Patients and Enhancing Understanding of Drug Tolerability in Early Clinical Development: PROACT
title_sort erratum to: development and evaluation of a new technological way of engaging patients and enhancing understanding of drug tolerability in early clinical development: proact
topic Erratum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5020106/
https://www.ncbi.nlm.nih.gov/pubmed/27464766
http://dx.doi.org/10.1007/s12325-016-0390-x
work_keys_str_mv AT hughesandrew erratumtodevelopmentandevaluationofanewtechnologicalwayofengagingpatientsandenhancingunderstandingofdrugtolerabilityinearlyclinicaldevelopmentproact
AT landersdonal erratumtodevelopmentandevaluationofanewtechnologicalwayofengagingpatientsandenhancingunderstandingofdrugtolerabilityinearlyclinicaldevelopmentproact
AT arkenauhendriktobias erratumtodevelopmentandevaluationofanewtechnologicalwayofengagingpatientsandenhancingunderstandingofdrugtolerabilityinearlyclinicaldevelopmentproact
AT shahsaj erratumtodevelopmentandevaluationofanewtechnologicalwayofengagingpatientsandenhancingunderstandingofdrugtolerabilityinearlyclinicaldevelopmentproact
AT stephensrichard erratumtodevelopmentandevaluationofanewtechnologicalwayofengagingpatientsandenhancingunderstandingofdrugtolerabilityinearlyclinicaldevelopmentproact
AT mahalamrik erratumtodevelopmentandevaluationofanewtechnologicalwayofengagingpatientsandenhancingunderstandingofdrugtolerabilityinearlyclinicaldevelopmentproact
AT simmonsmatthew erratumtodevelopmentandevaluationofanewtechnologicalwayofengagingpatientsandenhancingunderstandingofdrugtolerabilityinearlyclinicaldevelopmentproact
AT lemechcharlotte erratumtodevelopmentandevaluationofanewtechnologicalwayofengagingpatientsandenhancingunderstandingofdrugtolerabilityinearlyclinicaldevelopmentproact
AT roylejennifer erratumtodevelopmentandevaluationofanewtechnologicalwayofengagingpatientsandenhancingunderstandingofdrugtolerabilityinearlyclinicaldevelopmentproact